Day: November 5, 2025

Press ReleaseNokia extends SoftBank Corp. partnership with network modernization deal in JapanNokia selected to modernize and expand SoftBank’s 4G and 5G networks in Japan Deal includes Nokia’s latest AirScale portfolio and AI-powered MantaRay solution5 November 2025 Espoo, Finland – Nokia today announced an expansion of its partnership with SoftBank Corp. (SoftBank) through a new deal to supply advanced 4G and 5G radio access equipment in Japan. The agreement encompasses the modernization of existing network infrastructure and the expansion of 5G standalone coverage using Nokia’s cutting-edge AirScale portfolio. The deployment will take place across Western Japan. Under this agreement, Nokia will deploy its energy-efficient AirScale Radio Access Network (RAN) solutions, featuring the latest Habrok Massive MIMO...

Presentation will highlight preclinical data supporting the potential of WVE-007 (INHBE GalNAc-siRNA) as a unique approach for the treatment of obesity designed to drive fat loss while preserving muscle mass with once or twice annual dosing In preclinical models, INHBE GalNAc-siRNA led to adipocyte shrinkage, fewer pro-inflammatory macrophages, less fibrosis, and improved insulin sensitivity in visceral adipose tissue, supporting potential for metabolic improvement As an add-on to semaglutide, Wave’s GalNAc-siRNA doubled weight loss in mice and prevented weight regain upon cessation of semaglutide INLIGHT clinical study evaluating WVE-007 is ongoing: last week Wave announced positive target engagement, including dose-dependent decreases in Activin E (up to 85%) observed one month post-single dose of WVE-007, exceeding the reductions seen...

London, UK, Nov. 04, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital Corp (“AlphaTON Capital” or the “Company”) (Nasdaq: ATON) – AlphaTON Capital, a leading investment firm focused on disruptive technologies, today announced it has acquired an additional 300,000 TON Coin to add to its TON Digital Asset Treasury. About AlphaTON Capital Corp. (Nasdaq: ATON) AlphaTON Capital is a specialized digital asset company focused on developing the Telegram ecosystem and managing a strategic reserve of TON tokens. The Company implements a comprehensive M&A and treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, AlphaTON Capital provides public market investors with institutional-grade...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces the completion of patient enrollment of SAFFRON, a global Phase III study of ORPATHYS® (savolitinib) and TAGRISSO® (osimertinib) for the treatment of patients with epidermal growth factor receptor (“EGFR”)-mutated, MET-overexpressed and/or amplified, locally advanced or metastatic non-small cell lung cancer (“NSCLC”) following progression on treatment with TAGRISSO®. The last patient was randomized on October 31, 2025. This combination represents a promising, chemotherapy-free, all-oral treatment option following progression on an EGFR tyrosine kinase inhibitor (“TKI”), and was granted approval in China in June 2025 based on the results of the SACHI randomized Phase III...